日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Metabolism, Disposition, Excretion, and Potential Transporter Inhibition of 7-16, an Improving 5-HT2A Receptor Antagonist and Inverse Agonist for Parkinson's Disease

7-16 的代谢、处置、排泄和潜在转运蛋白抑制，一种改善帕金森病的 5-HT2A 受体拮抗剂和反向激动剂

期刊:Molecules
影响因子:4.2
doi:10.3390/molecules29102184
Zhengping Hu, Wenyan Wang, Huijie Yang, Fengjuan Zhao, Chunjie Sha, Wei Mi, Shuying Yin, Hongbo Wang, Jingwei Tian, Liang Ye
代谢
神经
帕金森
发表日期：2024
文献求助 收藏

Pharmacological and toxicological studies of a novel goserelin acetate extended-release microspheres in rats.

对新型戈舍瑞林醋酸盐缓释微球在大鼠体内的药理学和毒理学研究

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2023.1125255
Yutong Mao, Liang Ye, Chunjie Sha, Xiaolin Guan, Xiaoyan Gong, Lin Dong, Guangying Du, Xuemei Zhang, Xiaobo Cen, Jingwei Tian, Pengfei Yu, Hongbo Wang
其它
Rat
发表日期：2023
文献求助 收藏

Structure and function analysis of a potent human neutralizing antibody CA521FALA against SARS-CoV-2

对一种强效人源中和抗体CA521FALA抗SARS-CoV-2的结构和功能分析

期刊:Communications Biology
影响因子:5.2
doi:10.1038/s42003-021-02029-w
Deyong Song # ，Wenbo Wang # ，Chuangchuang Dong ，Zhenfei Ning ，Xiu Liu ，Chuan Liu ，Guangying Du ，Chunjie Sha ，Kailin Wang ，Jun Lu ，Baiping Sun ，Yanyan Zhao ，Qiaoping Wang ，Hongguang Xu ，Ying Li ，Zhenduo Shen ，Jie Jiao ，Ruiying Wang ，Jingwei Tian ，Wanhui Liu ，Lan Wang ，Yong-Qiang Deng ，Changlin Dou
SARS-CoV-2
发表日期：2021
文献求助 收藏

Two novel human anti-CD25 antibodies with antitumor activity inversely related to their affinity and in vitro activity

两种新型人源抗CD25抗体的抗肿瘤活性与其亲和力和体外活性呈负相关

期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-021-02449-y
Deyong Song # ，Xiu Liu # ，Chuangchuang Dong ，Qiaoping Wang ，Chunjie Sha ，Chuan Liu ，Zhenfei Ning ，Jing Han ，Hong Liu ，Mengqi Zong ，Yanyan Zhao ，Ying Li ，Guangsheng Liu ，Xin Shao ，Changlin Dou
CD2
肿瘤免疫
CD25
肿瘤
发表日期：2021
文献求助 收藏